Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung disease.
Yong-Bum ParkAnna-Maria Hoffmann-VoldMarco Matucci-CerinicLesley Ann SaketkooKristin B HighlandHilary WilsonMargarida AlvesElvira ErhardtNils SchoofToby M MaherPublished in: Rheumatology (Oxford, England) (2022)
clinicaltrials.gov, www.clinicaltrials.gov, NCT02597933.